Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Momentum Bioscience

Founders Bill Mullen


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Rounds per year 0.06
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Clinical Trials
  • Health Care
  • Health Diagnostics

Momentum Bioscience appeared to be the Corporate Investor, which was created in 2005. The main office of represented Corporate Investor is situated in the Reading. The fund was located in Europe if to be more exact in United Kingdom.

The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Cycad Group. In the next rounds fund is usually obtained by Nextech Invest, Cycad Group, Parker Institute for Cancer Immunotherapy.

Among the various public portfolio startups of the fund, we may underline ImaginAb For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Clinical Trials.

The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2012.

The fund was created by Bill Mullen.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Advantedge Technologies India, Maharashtra, Mumbai
Bangor Angels Bangor, Maine, United States
Bertram Capital Management California, San Mateo, United States
Capikris Foundation Central Region, Singapore, Singapore
EMVC District of Columbia, United States, Washington
Freescale Semiconductor Austin, Texas, United States
Greyhound Capital England, London, United Kingdom
HGGC California, Palo Alto, United States
Incubadora Sinergia Montevideo, Uruguay
Kolibra Capital Indonesia, Jakarta, Jakarta Raya
Motilal Oswal Private Equity India, Maharashtra, Mumbai
Network Solutions Herndon, United States, Virginia
PH Investment China, Shanghai
Premiere Partners -
RAD BioMed Accelerator Israel, Tel Aviv, Tel Aviv District
Research Frontiers New York, United States, Woodbury
Siena Holdings Plano, Texas, United States
St. Louis Economic Development Partnership Missouri, St Louis, United States
Sterling.VC New York, New York, United States
Tech Alliance Corp England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Clinical Trials
Health Care
Health Diagnostics
$12M27 Mar 2012 Inglewood, California, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Momentum Bioscience?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: